Navitor Pharmaceuticals, Inc.
Clinical trials sponsored by Navitor Pharmaceuticals, Inc., explained in plain language.
-
New hope for hard-to-treat depression? drug tested in 250 adults.
Symptom relief CompletedThis study tested an experimental drug called NV-5138 in 250 adults whose depression did not improve with standard treatments. The goal was to see if the drug could reduce depression symptoms better than a placebo over 4 weeks. The study is complete, and results will show if this…
Phase: PHASE2 • Sponsor: Navitor Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 26, 2026 11:47 UTC
-
New depression pill shows promise in early trial
Symptom relief CompletedThis study tested an experimental drug called SPN-820 in 40 adults with major depressive disorder. The goal was to see if the drug safely reduces depression symptoms. Researchers measured changes in mood and daily function over time using standard depression rating scales.
Phase: PHASE2 • Sponsor: Navitor Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 26, 2026 11:08 UTC